McKesson Corporation (NYSE:MCK) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

McKesson Corporation (NYSE:MCK) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Story continues below

On July 9, 2018, Erin M. Lampert, Senior Vice President and Chief Accounting Officer, notified McKesson Corporation (“McKesson” or the “Company”) of her intention to resign from her role effective July 25, 2018. She will remain with the Company for a transition period ending in early August. The Company plans to appoint Sundeep Reddy as Senior Vice President, Corporate Controller effective July 25, 2018. In that role, Mr. Reddy will serve as our principal accounting officer.

Mr. Reddy, age 45, is currently Senior Vice President, Assistant Controller. He joined McKesson in 2013 as Vice President & Controller, McKesson Technology Solutions, progressing to his current role, where he leads a team focused on global consolidations and reporting, external (SEC) reporting, technical accounting, corporate general ledger and financial applications.

Mr.Reddy has no familial relationships or related party transactions with the Company that would require disclosure under Items401(d) or 404(a) of RegulationS-K in connection with his appointment described above.

Mr.Reddy has a Bachelor’s degree in Accounting from Georgia State, an MBA from Emory University and is a CPA.


About McKesson Corporation (NYSE:MCK)

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.

An ad to help with our costs